Notify me when Xiaolin Wang files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RVMD, RVMDW | Revolution Medicines, Inc. | EVP, Clinical Development | $4.14M | Mar 17, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|